GranuFlo® and NaturaLyte® Lawsuit


About GranuFlo® and NaturaLyte®
GranuFlo® and NaturaLyte®, products used in kidney dialysis treatments, have been linked to reports of dangerous and life-threatening side effects including:
  • Sudden cardiac death
  • Heart attack
  • Cardiovascular death
  • Cardiopulmonary arrest
  • Other cardiovascular injuries

If symptoms arise following dialysis, patients should seek medical attention and consider pursuing a NaturaLyte® lawsuit.

PURSUE A NaturaLyte® lawsuit

You may want to pursue a NaturaLyte® lawsuit if you have chronic kidney failure or require dialysis treatment and have experienced adverse side effects. Fresenius, the maker of GranuFlo® and NaturaLyte®, is aware that its products can cause alkalosis, a condition associated with an increase in cardiovascular death and catastrophic cardiovascular injuries. In fact, on March 29, 2012, Fresenius issued an “urgent product notification” with “important prescribing information” warning about increased risk associated with these products.


Fresenius withheld information about the adverse effects risk, which came from its own internal analysis of GranuFlo® or NaturaLyte® in dialysis patients. An internal memo from Fresenius Medical Care North America (FMC) dated Nov. 4, 2011 indicates that FMC had knowledge that their GranuFlo® and NaturaLyte® dialysis products significantly increased the risk of cardiac arrest and death during hemodialysis treatments.Is a NaturaLyte® lawsuit right for you? If you are receiving dialysis with NaturaLyte® or GranuFlo® and have been injured, you may be able to pursue a NaturaLyte® lawsuit.


[contact-form-7 404 "Not Found"]